TY  - JOUR

T1  - Laboratory safety of dupilumab in patients aged 6–11 years with severe atopic dermatitis : results from a phase III clinical trial

JO  - Pediatric Drugs

PY  - 2021/09/01

AU  - Paller AS

AU  - Wollenberg A

AU  - Siegfried E

AU  - Thaçi D

AU  - Cork MJ

AU  - Arkwright PD

AU  - Gooderham M

AU  - Sun X

AU  - O’Malley JT

AU  - Khokhar FA

AU  - Vakil J et al

ED  - 

DO  - DOI: 10.1007/s40272-021-00459-x

PB  - Springer Nature

VL  - 23

IS  - 5

SP  - 515

EP  - 527

Y2  - 2024/12/22

ER  -